OBJECTIVE: To evaluate the roles of folic acid and beta-carotene in the chemoprevention of gastric and other gastrointestinal (GI) cancers. METHODS: In a randomized, double-blind, placebo-controlled trial, a total of ...OBJECTIVE: To evaluate the roles of folic acid and beta-carotene in the chemoprevention of gastric and other gastrointestinal (GI) cancers. METHODS: In a randomized, double-blind, placebo-controlled trial, a total of 216 patients with atrophic gastritis were randomly assigned to one of the four groups: (1) folate (FA, 20 mg per day plus vitamin B(12) 1 mg, intramuscularly, per month for one year, then 20 mg two times a week plus 1 mg per three months for the next year); (2) natural beta-carotene (N-betaC, 30 mg per day for first year, then 30 mg two times a week for the next); (3) synthetic beta-carotene (S-betaC, administered as in N-betaC); and (4) placebo. Follow-ups continued from 1994 to 2001. RESULTS: A total of 7 new cases of gastrointestinal cancers were diagnosed with 3 stomach, 1 colon and 1 esophageal cancers occurring in the placebo group; 1 stomach cancer in both of the N-betaC and S-betaC groups, and no cancer occurring in FA group. In terms of GI cancers, there was a significant reduction in the FA group, compared with the placebo group (P = 0.04). A similar trend was observed in both N-betaC and S-betaC groups (P = 0.07 - 0.08). Taken together, the three intervention groups displayed a highly significant decrease in occurrence (P = 0.004, vs placebo), and a lower risk for GI cancers (OR = 0.12; 95% confidence interval, 0.03 - 0.51). For development of gastric cancer, any one of the three active-treated groups did not reach statistically significant reduction. The FA group showed obvious improvement of the gastric mucosal lesions with more patients displaying lesions reversed or stable atrophy and inflammation (P = 0.04), reversed intestinal metaplasia (P = 0.06) at the end of follow-up, and reversed displasia (P = 0.017) at 12 months. Two cases of false jaundice were found in beta-carotene groups with no influence on administration, and no side-effects were reported in FA group. CONCLUSIONS: This trial revealed the interventional effect of folic acid on the development of GI cancers, a similar eff展开更多
Abdominal cocoon syndrome is a rare cause of intestinal obstruction with unknown etiology. Diagnosis of this syndrome, which can be summarized as the small intestine being surrounded by a fibrous capsule not containin...Abdominal cocoon syndrome is a rare cause of intestinal obstruction with unknown etiology. Diagnosis of this syndrome, which can be summarized as the small intestine being surrounded by a fibrous capsule not containing the mesothelium, is difficult in the preoperative period. A 47-year-old male patient was referred to the emergency department with complaints of abdominal pain, nausea, and vomiting for two days. The abdominal computed tomography examination detected dilated small intestinal loops containing air-fluid levels clustered in the left upper quadrant of the abdomen and surrounded by a thick, saclike, contrast-enhanced membrane. During exploratory surgery, a capsular structure was identified in the upper left quadrant with a regular surface that was solid-fibrous in nature. Ab-dominal cocoon syndrome is a rarely seen condition, for which the preoperative diagnosis is difficult. The combination of physical examination and radiological signs, and the knowledge of "recurrent characteristics of the complaints" that can be learned by a careful history, may be helpful in diagnosis.展开更多
Background Developmental dysplasia encompasses a wide spectrum of hip pathology ranging from a shallow acetabulum to a completely dislocated ＇high-riding＇ hip. It is a common cause of secondary osteoarthritis in you...Background Developmental dysplasia encompasses a wide spectrum of hip pathology ranging from a shallow acetabulum to a completely dislocated ＇high-riding＇ hip. It is a common cause of secondary osteoarthritis in young adults and is the underlying diagnosis in up to 48% of patients requiring total hip arthroplasty （THA） for coxarthrosis. The aim of this study was to evaluate efficiency and safety of THA using Zweym（311er hip implant in the treatment of severe osteoarthritis secondary to developmental dysplasia of the hip （DDH） in adults. Methods From January 2000 to February 2008, 35 patients （40 hips） with developmental dysplasia of the hip were included. Five were male and 30 were female, with ages ranging from 26 to 65 years and an average age of 45 years. According to Hartofilakidis classification, there were type I in 5 hips, type II in 20 hips, type III in 15 hips. All the patients were performed the THA using the Zweym011er hip implant. The preoperative average Harris score was 44. The bilateral arthroplasty was performed in 5 patients and the unilateral arthroplasty in 30 patients. The patients mainly suffered from pain and claudication. Clinical and radiological results were analyzed. The Harris score was used for outcome measurement. Results Thirty five patients （40 hips） were followed and the mean follow-up period was 46 months （ranged from 24 months to 96 months）. The latest follow-up average Harris score was 88.9 （97.1% of good rate）. All the patients were pain-free and there was no sign of infection, aseptic loosening and subsidence. Conclusions In summary, THA using Zweym011er hip implant is a good treatment method for severe osteoarthritis secondary to DDH in adults. The key techniques for the total hip replacement are as follows： good preoperative plan, firmly placing the acetabular component in the true acetabulum, proper preparation of proximal femur, suitable femoral component choosing and improving the techniques of the bone graft.展开更多
目的系统评价真实世界中贝利尤单抗治疗中国成人狼疮性肾炎(LN)患者的有效性和安全性。方法计算机检索PubMed、Embase、Web of Science、Cochrane Library、万方、中国知网、维普、中国生物医学文献数据库,搜集贝利尤单抗治疗中国成人L...目的系统评价真实世界中贝利尤单抗治疗中国成人狼疮性肾炎(LN)患者的有效性和安全性。方法计算机检索PubMed、Embase、Web of Science、Cochrane Library、万方、中国知网、维普、中国生物医学文献数据库,搜集贝利尤单抗治疗中国成人LN患者的真实世界研究,检索时限均从建库至2023年7月7日。由2位评价员独立筛选文献、提取资料并评价纳入研究的质量后,采用RevMan 5.3软件进行Meta分析。结果共纳入10篇真实世界研究,包括253例中国成人LN患者。Meta分析结果显示,贝利尤单抗治疗中国成人LN患者的肾脏完全缓解率、肾脏部分缓解率、不良反应发生率分别为61%(95%CI为46%~76%,P<0.00001)、23%(95%CI为2%~44%,P=0.03)、30%(95%CI为16%~43%,P<0.00001);贝利尤单抗可显著降低24 h尿蛋白水平(MD=-1.71,95%CI为-3.02~-0.40,P=0.01)、尿总蛋白肌酐比值(MD=-1.76,95%CI为-2.06~-1.46,P<0.00001)、系统性红斑狼疮疾病活动度指数(MD=-8.63,95%CI为-12.12~-5.13,P<0.00001)和糖皮质激素用量(MD=-18.65,95%CI为-31.82~-5.48,P=0.006),显著升高补体C3水平(MD=0.19,95%CI为0.08~0.30,P=0.0006)和补体C4水平(MD=0.06,95%CI为0.02~0.09,P=0.001),但不能改善血清肌酐水平和估算肾小球滤过率(P>0.05)。结论贝利尤单抗对中国成人LN患者具有良好的有效性和安全性。展开更多
AIM:Capsule endoscopy has demonstrated its clinical utility in the evaluation of small bowel pathology in several Western studies.In this prospective study,we aimed to determine the clinical utility,safety and tolerab...AIM:Capsule endoscopy has demonstrated its clinical utility in the evaluation of small bowel pathology in several Western studies.In this prospective study,we aimed to determine the clinical utility,safety and tolerability of capsule endoscopy in the evaluation of suspected small bowel disease in an urban Southeast Asian population. METHODS:We used the given (M2A) capsule endoscopy system in 16 consecutive patients with suspected small bowel pathology.In 9 patients the indication was obscure gastrointestinal bleeding,while in 6 patients it was to determine the extent of small bowel involvement in Crohn's disease.One patient underwent capsule endoscopy for evaluation of chronic abdominal pain.Patient's tolerability to the procedure was evaluated by standardized questionnaires and all patients were reviewed at one week to ensure that the capsule had been excreted without any adverse events. RESULTS:Abnormal findings were present in 8 patients (50%).The cause of obscure gastrointestinal bleeding was determined in 5 out of 9 patients.Findings included 2 cases of angiodysplasia,2 cases of jejunal ulcers and 1 case of both angiodysplasia and jejunal ulcer.One patient had small bowel erosions and loci of erythema of doubtful significance. Ileal lesions were diagnosed in 2 out of 6 patients with Crohn's disease.Capsule endoscopy was well tolerated by all patients.One patient with Crohn's disease had a complication of capsule retention due to terminal ileum stricture.The capsule eventually passed out spontaneously after i month. CONCLUSION:Our study,which represented the first Asian series,further confirms the diagnostic utility,safety and tolerability of wireless capsule endoscopy.展开更多
目的研制开发成年病人的万古霉素治疗药物监测软件,帮助临床进行万古霉素个体化用药。方法系统地检索PubMed数据库中发表于2012年9月前的文献,提取成年病人万古霉素群体药动学模型并结合笔者建立的模型构建万古霉素治疗药物监测模型集...目的研制开发成年病人的万古霉素治疗药物监测软件,帮助临床进行万古霉素个体化用药。方法系统地检索PubMed数据库中发表于2012年9月前的文献,提取成年病人万古霉素群体药动学模型并结合笔者建立的模型构建万古霉素治疗药物监测模型集。根据建立的群体药动学模型和Bayesian原理,在Microsoft Visual Studio 2005集成开发环境中采用C++语言研发治疗药物监测软件。结果构建的治疗药物监测模型集包含14个群体药动学模型。基于模型开发的软件可根据病人信息的多寡分别进行群体、亚群体和个体预测,为临床万古霉素个体化给药提供帮助。结论本实验研发的软件涵盖了当前报道的万古霉素药动学模型,医生可以根据病人的实际情况选择适当的模型,具有较广的适用性。展开更多
AIM: The fears and concerns are associated with gastroscopy (EGD) decrease patient compliance. Conscious sedation (CS) and non-pharmacological interventions have been proposed to reduce anxiety and allow better execut...AIM: The fears and concerns are associated with gastroscopy (EGD) decrease patient compliance. Conscious sedation (CS) and non-pharmacological interventions have been proposed to reduce anxiety and allow better execution of EGD. The aim of this study was to assess whether CS, supplementary information with a videotape, or presence of a relative during the examination could improve the tolerance to EGD. METHODS: Two hundred and twenty-six outpatients (pts), scheduled for a first-time non-emergency EGD were randomly assigned to 4 groups: Co-group (62 pts): throat anaesthesia only; Mi-group (52 pts): CS with i.v. midazolam; Re-group (58 pts): presence of a relative throughout the procedure; Vi-group (54 pts): additional information with a videotape. Anxiety was measured using the “Spielberger State and Trait Anxiety Scales” The patients assessed the overall discomfort during the procedure on an 100-mm visual analogue scale, and their tolerance to EGD answering a questionnaire. The endoscopist evaluated the technical difficulty of the examination and the tolerance of the patients on an 100-mm visual analogue scale and answering a questionnaire. RESULTS: Pre-endoscopy anxiety levels were higher in the Mi-group than in the other groups (P<0.001). On the basis of the patients' evaluation, EGD was well tolerated by 80.7% of patients in Mi-group, 43.5% in Co-group, 58.6% in Regroup, and 50% in Vi-group (P<0.01). The discomfort caused by EGD, evaluated by either the endoscopist or the patients, was lower in Mi-group than in the other groups. The discomfort was correlated with “age” (P<0.001) and “groups of patients” (P<0.05) in the patients' evaluation, and with “gender” (females tolerated better than males, P<0.001) and “groups of patients” (P<0.05) in the endoscopist's evaluation. CONCLUSION: Conscious sedation can improve the tolerance to EGD. Male gender and young age are predictive factors of bad tolerance to the procedure.展开更多
基金ThisresearchwaspartlysupportedbytheNationalNaturalScienceFoundationofChina (No 39370 332 )
文摘OBJECTIVE: To evaluate the roles of folic acid and beta-carotene in the chemoprevention of gastric and other gastrointestinal (GI) cancers. METHODS: In a randomized, double-blind, placebo-controlled trial, a total of 216 patients with atrophic gastritis were randomly assigned to one of the four groups: (1) folate (FA, 20 mg per day plus vitamin B(12) 1 mg, intramuscularly, per month for one year, then 20 mg two times a week plus 1 mg per three months for the next year); (2) natural beta-carotene (N-betaC, 30 mg per day for first year, then 30 mg two times a week for the next); (3) synthetic beta-carotene (S-betaC, administered as in N-betaC); and (4) placebo. Follow-ups continued from 1994 to 2001. RESULTS: A total of 7 new cases of gastrointestinal cancers were diagnosed with 3 stomach, 1 colon and 1 esophageal cancers occurring in the placebo group; 1 stomach cancer in both of the N-betaC and S-betaC groups, and no cancer occurring in FA group. In terms of GI cancers, there was a significant reduction in the FA group, compared with the placebo group (P = 0.04). A similar trend was observed in both N-betaC and S-betaC groups (P = 0.07 - 0.08). Taken together, the three intervention groups displayed a highly significant decrease in occurrence (P = 0.004, vs placebo), and a lower risk for GI cancers (OR = 0.12; 95% confidence interval, 0.03 - 0.51). For development of gastric cancer, any one of the three active-treated groups did not reach statistically significant reduction. The FA group showed obvious improvement of the gastric mucosal lesions with more patients displaying lesions reversed or stable atrophy and inflammation (P = 0.04), reversed intestinal metaplasia (P = 0.06) at the end of follow-up, and reversed displasia (P = 0.017) at 12 months. Two cases of false jaundice were found in beta-carotene groups with no influence on administration, and no side-effects were reported in FA group. CONCLUSIONS: This trial revealed the interventional effect of folic acid on the development of GI cancers, a similar eff
文摘Abdominal cocoon syndrome is a rare cause of intestinal obstruction with unknown etiology. Diagnosis of this syndrome, which can be summarized as the small intestine being surrounded by a fibrous capsule not containing the mesothelium, is difficult in the preoperative period. A 47-year-old male patient was referred to the emergency department with complaints of abdominal pain, nausea, and vomiting for two days. The abdominal computed tomography examination detected dilated small intestinal loops containing air-fluid levels clustered in the left upper quadrant of the abdomen and surrounded by a thick, saclike, contrast-enhanced membrane. During exploratory surgery, a capsular structure was identified in the upper left quadrant with a regular surface that was solid-fibrous in nature. Ab-dominal cocoon syndrome is a rarely seen condition, for which the preoperative diagnosis is difficult. The combination of physical examination and radiological signs, and the knowledge of "recurrent characteristics of the complaints" that can be learned by a careful history, may be helpful in diagnosis.
文摘Background Developmental dysplasia encompasses a wide spectrum of hip pathology ranging from a shallow acetabulum to a completely dislocated ＇high-riding＇ hip. It is a common cause of secondary osteoarthritis in young adults and is the underlying diagnosis in up to 48% of patients requiring total hip arthroplasty （THA） for coxarthrosis. The aim of this study was to evaluate efficiency and safety of THA using Zweym（311er hip implant in the treatment of severe osteoarthritis secondary to developmental dysplasia of the hip （DDH） in adults. Methods From January 2000 to February 2008, 35 patients （40 hips） with developmental dysplasia of the hip were included. Five were male and 30 were female, with ages ranging from 26 to 65 years and an average age of 45 years. According to Hartofilakidis classification, there were type I in 5 hips, type II in 20 hips, type III in 15 hips. All the patients were performed the THA using the Zweym011er hip implant. The preoperative average Harris score was 44. The bilateral arthroplasty was performed in 5 patients and the unilateral arthroplasty in 30 patients. The patients mainly suffered from pain and claudication. Clinical and radiological results were analyzed. The Harris score was used for outcome measurement. Results Thirty five patients （40 hips） were followed and the mean follow-up period was 46 months （ranged from 24 months to 96 months）. The latest follow-up average Harris score was 88.9 （97.1% of good rate）. All the patients were pain-free and there was no sign of infection, aseptic loosening and subsidence. Conclusions In summary, THA using Zweym011er hip implant is a good treatment method for severe osteoarthritis secondary to DDH in adults. The key techniques for the total hip replacement are as follows： good preoperative plan, firmly placing the acetabular component in the true acetabulum, proper preparation of proximal femur, suitable femoral component choosing and improving the techniques of the bone graft.
文摘AIM:Capsule endoscopy has demonstrated its clinical utility in the evaluation of small bowel pathology in several Western studies.In this prospective study,we aimed to determine the clinical utility,safety and tolerability of capsule endoscopy in the evaluation of suspected small bowel disease in an urban Southeast Asian population. METHODS:We used the given (M2A) capsule endoscopy system in 16 consecutive patients with suspected small bowel pathology.In 9 patients the indication was obscure gastrointestinal bleeding,while in 6 patients it was to determine the extent of small bowel involvement in Crohn's disease.One patient underwent capsule endoscopy for evaluation of chronic abdominal pain.Patient's tolerability to the procedure was evaluated by standardized questionnaires and all patients were reviewed at one week to ensure that the capsule had been excreted without any adverse events. RESULTS:Abnormal findings were present in 8 patients (50%).The cause of obscure gastrointestinal bleeding was determined in 5 out of 9 patients.Findings included 2 cases of angiodysplasia,2 cases of jejunal ulcers and 1 case of both angiodysplasia and jejunal ulcer.One patient had small bowel erosions and loci of erythema of doubtful significance. Ileal lesions were diagnosed in 2 out of 6 patients with Crohn's disease.Capsule endoscopy was well tolerated by all patients.One patient with Crohn's disease had a complication of capsule retention due to terminal ileum stricture.The capsule eventually passed out spontaneously after i month. CONCLUSION:Our study,which represented the first Asian series,further confirms the diagnostic utility,safety and tolerability of wireless capsule endoscopy.
文摘目的研制开发成年病人的万古霉素治疗药物监测软件,帮助临床进行万古霉素个体化用药。方法系统地检索PubMed数据库中发表于2012年9月前的文献,提取成年病人万古霉素群体药动学模型并结合笔者建立的模型构建万古霉素治疗药物监测模型集。根据建立的群体药动学模型和Bayesian原理,在Microsoft Visual Studio 2005集成开发环境中采用C++语言研发治疗药物监测软件。结果构建的治疗药物监测模型集包含14个群体药动学模型。基于模型开发的软件可根据病人信息的多寡分别进行群体、亚群体和个体预测,为临床万古霉素个体化给药提供帮助。结论本实验研发的软件涵盖了当前报道的万古霉素药动学模型,医生可以根据病人的实际情况选择适当的模型,具有较广的适用性。
文摘AIM: The fears and concerns are associated with gastroscopy (EGD) decrease patient compliance. Conscious sedation (CS) and non-pharmacological interventions have been proposed to reduce anxiety and allow better execution of EGD. The aim of this study was to assess whether CS, supplementary information with a videotape, or presence of a relative during the examination could improve the tolerance to EGD. METHODS: Two hundred and twenty-six outpatients (pts), scheduled for a first-time non-emergency EGD were randomly assigned to 4 groups: Co-group (62 pts): throat anaesthesia only; Mi-group (52 pts): CS with i.v. midazolam; Re-group (58 pts): presence of a relative throughout the procedure; Vi-group (54 pts): additional information with a videotape. Anxiety was measured using the “Spielberger State and Trait Anxiety Scales” The patients assessed the overall discomfort during the procedure on an 100-mm visual analogue scale, and their tolerance to EGD answering a questionnaire. The endoscopist evaluated the technical difficulty of the examination and the tolerance of the patients on an 100-mm visual analogue scale and answering a questionnaire. RESULTS: Pre-endoscopy anxiety levels were higher in the Mi-group than in the other groups (P<0.001). On the basis of the patients' evaluation, EGD was well tolerated by 80.7% of patients in Mi-group, 43.5% in Co-group, 58.6% in Regroup, and 50% in Vi-group (P<0.01). The discomfort caused by EGD, evaluated by either the endoscopist or the patients, was lower in Mi-group than in the other groups. The discomfort was correlated with “age” (P<0.001) and “groups of patients” (P<0.05) in the patients' evaluation, and with “gender” (females tolerated better than males, P<0.001) and “groups of patients” (P<0.05) in the endoscopist's evaluation. CONCLUSION: Conscious sedation can improve the tolerance to EGD. Male gender and young age are predictive factors of bad tolerance to the procedure.
